Matica Biotechnology, Inc. ("Matica Bio"), a leading viral vector CDMO specializing in advanced therapies, today announced a strategic partnership with Calidi Biotherapeutics, Inc. ("Calidi"), a ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
Matica Biotechnology, a United States contract development and manufacturing organization under Korea’s Cha Biotech, said Monday that it had signed a partnershi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback